Question 1

What is Trevi Therapeutics?

Accepted Answer

Trevi Therapeutics is a Company.

Question 2

How often does Trevi Therapeutics appear in global news?

Accepted Answer

Tracked across 2 news events drawn from 13 articles.

Question 3

When was Trevi Therapeutics first tracked by Ergen?

Accepted Answer

First tracked on Apr 01, 2026.

Question 4

When was Trevi Therapeutics last mentioned in news?

Accepted Answer

Last active on Jun 17, 2026.

Question 5

What is Trevi Therapeutics's current news sentiment?

Accepted Answer

Aggregate sentiment score: 10 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Trevi Therapeutics in global news coverage?

Accepted Answer

Attention score of 4, derived from article volume and coverage intensity across 2 events.

Question 7

What is the most recent event involving Trevi Therapeutics?

Accepted Answer

Trevi Therapeutics Prices $150M Offering (Apr 16, 2026, 7 articles).

Question 8

How did the "Trevi Therapeutics Prices $150M Offering" event impact Trevi Therapeutics?

Accepted Answer

Trevi Therapeutics announced the pricing of its underwritten public offering of common stock, expecting to raise $150 million. This offering will provide capital for the company's operations and development of Haduvio.

Question 9

How did the "Trevi Therapeutics Q1 2026 Earnings Call" event impact Trevi Therapeutics?

Accepted Answer

Trevi Therapeutics announced an upcoming conference call to discuss its first quarter 2026 financial results and provide a corporate update. This event is a routine financial disclosure for the company.

Question 10

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.